30
Apr
Annual Audited Accounts - 31 Dec 2025
30
Apr
AUDIT REPORT - MODIFIED OPINION / MATERIAL UNCERTAINTY RELATED TO GOING CONCERN : MATERIAL UNCERTAINTY RELATED TO GOING CONCERN
27
Feb
Half yearly rpt on consolidated results for the financial period ended 31/12/2025
24
Dec
OTHERS
PRIVATE PLACEMENT OF UP TO 11,568,908 NEW ORDINARY SHARES IN SUPERGENICS, REPRESENTING UP TO APPROXIMATELY 10% OF THE TOTAL EXISTING NUMBER OF ISSUED SHARES OF SUPERGENICS PURSUANT TO SECTIONS 75 AND 76 OF THE COMPANIES ACT 2016 ("ACT") ("PRIVATE PLACEMENT")
05
Dec
OTHERS
PROPOSED PRIVATE PLACEMENT OF UP TO 11,568,908 NEW ORDINARY SHARES IN SUPERGENICS, REPRESENTING UP TO APPROXIMATELY 10% OF THE TOTAL EXISTING NUMBER OF ISSUED SHARES OF SUPERGENICS PURSUANT TO SECTIONS 75 AND 76 OF THE COMPANIES ACT 2016 ("ACT") ("PROPOSED PRIVATE PLACEMENT")
03
Sep
OTHERS
PROPOSED PRIVATE PLACEMENT OF UP TO 11,568,908 NEW ORDINARY SHARES IN SUPERGENICS, REPRESENTING UP TO APPROXIMATELY 10% OF THE TOTAL EXISTING NUMBER OF ISSUED SHARES OF SUPERGENICS PURSUANT TO SECTIONS 75 AND 76 OF THE COMPANIES ACT 2016 ("ACT") ("PROPOSED PRIVATE PLACEMENT")
02
Sep
Additional Listing Announcement /Subdivision of Shares
29
Aug
Half yearly rpt on consolidated results for the financial period ended 30/06/2025
27
Aug
OTHERS
PROPOSED PRIVATE PLACEMENT OF UP TO 11,568,908 NEW ORDINARY SHARES IN SUPERGENICS, REPRESENTING UP TO APPROXIMATELY 10% OF THE TOTAL EXISTING NUMBER OF ISSUED SHARES OF SUPERGENICS PURSUANT TO SECTIONS 75 AND 76 OF THE COMPANIES ACT 2016 ("ACT") ("PROPOSED PRIVATE PLACEMENT")
12
Aug
Change in Boardroom - MISS LAU MENG HONG
24
Jun
OTHERS
PROPOSED PRIVATE PLACEMENT OF UP TO 11,568,908 NEW ORDINARY SHARES IN SUPERGENICS, REPRESENTING UP TO APPROXIMATELY 10% OF THE TOTAL EXISTING NUMBER OF ISSUED SHARES OF SUPERGENICS PURSUANT TO SECTIONS 75 AND 76 OF THE COMPANIES ACT 2016 ("ACT") ("PROPOSED PRIVATE PLACEMENT")
13
Jun
General Meetings: Outcome of Meeting
29
May
OTHERS
PROPOSED PRIVATE PLACEMENT OF UP TO 11,568,908 NEW ORDINARY SHARES IN SUPERGENICS, REPRESENTING UP TO APPROXIMATELY 10% OF THE TOTAL EXISTING NUMBER OF ISSUED SHARES OF SUPERGENICS PURSUANT TO SECTIONS 75 AND 76 OF THE COMPANIES ACT 2016 ("ACT") ("PROPOSED PRIVATE PLACEMENT")
21
May
General Meetings: Notice of Meeting
07
May
Notice of Person Ceasing (Section 139 of CA 2016) - MR LOW WEI HENG
02
May
Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - MR LOW WEI HENG
02
May
Notice of Person Ceasing (Section 139 of CA 2016) - MISS LAU MENG HONG
02
May
Changes in Director's Interest (Section 219 of CA 2016) - MISS LAU MENG HONG
30
Apr
Annual Audited Accounts - 31 Dec 2024
30
Apr
OTHERS
PROPOSED PRIVATE PLACEMENT OF UP TO 11,568,908 NEW ORDINARY SHARES IN SUPERGENICS, REPRESENTING UP TO APPROXIMATELY 10% OF THE TOTAL EXISTING NUMBER OF ISSUED SHARES OF SUPERGENCIS PURSUANT TO SECTIONS 75 AND 76 OF THE COMPANIES ACT 2016 ("ACT") ("PROPOSED PRIVATE PLACEMENT")
21
Mar
Change of Address
04
Mar
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR TAN BII CHAU
04
Mar
Changes in Director's Interest (Section 219 of CA 2016) - MR TAN BII CHAU
04
Mar
Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - MISS LAU MENG HONG
04
Mar
Changes in Director's Interest (Section 219 of CA 2016) - MISS LAU MENG HONG
28
Feb
Half yearly rpt on consolidated results for the financial period ended 31/12/2024
15
Oct
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING
SUPERGENICS BERHAD ("SUPERGENICS" OR THE "COMPANY")
PRIVATE PLACEMENT OF UP TO 26,000,000 NEW ORDINARY SHARES IN SUPERGENICS, REPRESENTING APPROXIMATELY 27.96% OF THE EXISTING TOTAL NUMBER OF ISSUED SHARES OF SUPERGENICS AT AN ISSUE PRICE TO BE DETERMINED AND ANNOUNCED LATER ("PRIVATE PLACEMENT")
30
Aug
Half yearly rpt on consolidated results for the financial period ended 30/06/2024
02
Jul
NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING
SUPERGENICS BERHAD ("SUPERGENICS" OR THE "COMPANY")
PRIVATE PLACEMENT OF UP TO 26,000,000 NEW ORDINARY SHARES IN SUPERGENICS, REPRESENTING APPROXIMATELY 27.96% OF THE EXISTING TOTAL NUMBER OF ISSUED SHARES OF SUPERGENICS AT AN ISSUE PRICE TO BE DETERMINED AND ANNOUNCED LATER ("PRIVATE PLACEMENT")
21
Jun
General Meetings: Outcome of Meeting